A potential Sycamore buyout sounded like good news--until analysts revealed the brutal reality behind the deal.

Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

S&P 500 rises Friday despite stagflation fears. Safe-haven stocks outperform, while Nvidia, Dell, and HP Inc. slide on ...

Wall Street’s main indexes were mixed in choppy trading on Friday as investors avoided large bets after data showed consumer ...

Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

The deal hype started in early-December, when the Wall Street Journal reported Walgreens was in talks to sell itself to Sycamore Partners. Read: Walgreens' stock could see its best day ever. Is a ...

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by ...

PE firm Sycamore Partners reportedly plans to split Walgreens Boots Alliance into three independent businesses if it successfully acquires the drugstore chain.

The private-equity suitor is planning on splitting up Walgreens' U.S. and U.K. pharmacy businesses, as well as its specialty ...